Open Label Safety Study in Acute Treatment of Migraine

NCT03266588 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

3019

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine, With or Without Aura

Interventions

DRUG: Rimegepant

Sponsor

Pfizer